Published in ISRN Oncol on June 22, 2011
Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review. World J Gastroenterol (2015) 0.91
Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens. HPB (Oxford) (2014) 0.85
Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases. Ann Surg Oncol (2015) 0.82
Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. J Surg Oncol (2016) 0.81
Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer. JMIR Res Protoc (2017) 0.77
Liver resection for colorectal metastases: results and prognostic factors with 10-year follow-up. Langenbecks Arch Surg (2014) 0.77
Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes. Clin Exp Metastasis (2016) 0.76
Extended pathology reporting of resection specimens of colorectal liver metastases: the significance of a tumour pseudocapsule. HPB (Oxford) (2012) 0.76
Appraisal of Laparoscopic Liver Resection in the Treatment of Liver Metastasis with Special Reference to Outcome in Colorectal Malignancies. Indian J Surg (2013) 0.75
Extreme liver resections with preservation of segment 4 only. World J Gastroenterol (2017) 0.75
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med (2004) 49.02
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med (2000) 18.12
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg (1984) 3.08
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65
Resection of liver metastases--when is it worthwhile? World J Surg (1987) 2.59
Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg (2006) 2.37
Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg (2007) 2.35
Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13
Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg (2003) 2.04
Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol (2006) 2.02
Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol (2002) 2.00
Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum (2003) 1.60
Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology (2001) 1.52
Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg (2002) 1.42
Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. Eur J Surg Oncol (2006) 1.23
Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery (2007) 1.21
Patient selection for hepatic resection of colorectal metastases. Arch Surg (1996) 1.13
Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg (2005) 1.09
The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg (2004) 1.08
Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg (1997) 1.07
Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol (2005) 1.07
Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. AJR Am J Roentgenol (1998) 1.02
Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. Arch Surg (2007) 0.97
Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases. J Surg Oncol (2009) 0.88
Treatment strategy for synchronous metastases of colorectal cancer: is hepatic resection after an observation interval appropriate? Langenbecks Arch Surg (2007) 0.81
A multicenter phase II study of "adjuvant" irinotecan following resection of colorectal hepatic metastases. Am J Clin Oncol (2005) 0.79
Expanding the indications for hepatic resection in patients with colorectal liver metastases. Ann Surg Oncol (2004) 0.77
Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin. Atherosclerosis (2009) 1.31
Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes. JAMA (2010) 1.03
IgG4 related pseudotumour (calcifying fibrous tumour) of adrenal gland. Pathology (2013) 1.01
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma. Oncology (2007) 0.95
BRET biosensors to study GPCR biology, pharmacology, and signal transduction. Front Endocrinol (Lausanne) (2012) 0.94
Aldose reductase genotypes and cardiorenal complications: an 8-year prospective analysis of 1,074 type 2 diabetic patients. Diabetes Care (2008) 0.87
Using a multi-staged strategy based on machine learning and mathematical modeling to predict genotype-phenotype risk patterns in diabetic kidney disease: a prospective case-control cohort analysis. BMC Nephrol (2013) 0.86
Accumulation of porcine insulin in the rat brain and cerebrospinal fluid following ocular application. J Ocul Pharmacol Ther (2003) 0.85
Predictive role of polymorphisms in interleukin-5 receptor alpha-subunit, lipoprotein lipase, integrin A2 and nitric oxide synthase genes on ischemic stroke in type 2 diabetes--an 8-year prospective cohort analysis of 1327 Chinese patients. Atherosclerosis (2010) 0.81
Predictive role of multilocus genetic polymorphisms in cardiovascular disease and inflammation-related genes on chronic kidney disease in Type 2 diabetes--an 8-year prospective cohort analysis of 1163 patients. Nephrol Dial Transplant (2011) 0.81
Pharmacokinetics of insulin uptake by ocular tissues and the role of cerebrospinal fluid in optic nerve insulin accumulation following topical insulin application. Optometry (2004) 0.79
Insulin and tropicamide accumulate in the contralateral, untreated eye of rats following ipsilateral topical administration by a mechanism that does not involve systemic uptake. Optometry (2003) 0.79
Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells. Stem Cells Dev (2013) 0.78
Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole. Neurosci Lett (2008) 0.77
In colorectal liver metastases, the presence of extrahepatic disease correlates with the pathology of the primary tumour. ISRN Oncol (2011) 0.77
Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours. ANZ J Surg (2012) 0.76
Keyframe Extraction from Laparoscopic Videos via Diverse and Weighted Dictionary Selection. IEEE J Biomed Health Inform (2020) 0.75
Real-time conductivity imaging of temperature and tissue property changes during radiofrequency ablation: an ex vivo model using weighted frequency difference. Bioelectromagnetics (2015) 0.75
Spontaneous bile leak 6 years after uneventful cholecystectomy. Gastrointest Endosc (2003) 0.75
A rare case of primary retroperitoneal mucinous neoplasm in a male patient. Pathology (2015) 0.75